Fluorescent proteins can be used as whole-cell labels or as fusion tags 1 . Enhanced GFP (EGFP) and its monomeric derivative mEGFP are suitable for either purpose. Oligomeric RFPs have been engineered as whole-cell labels. For example, DsRed was modified to create DsRed-Express 2 ; eqFP578 was modified to create TurboRFP 3 and Katushka 4 ; and eqFP611 was modified to create RFP611 (ref. 5) . Monomeric RFPs have also been engineered. For example, DsRed-Express was modified to create DsRed-Monomer 6 as well as mCherry and tdTomato 7 ; Kusabira-Orange was modified to generate mKO2 (ref. 8); TurboRFP was modified to generate TagRFP 3 and TagRFP-S158T 9 ; and Katushka was modified to generate mKate 4 .
Despite this abundance of options, anecdotal data suggest that the use of RFPs as whole-cell labels has been limited by cytotoxicity. Whole-cell labeling typically employs strong promoters, and cells containing high levels of fluorescent proteins may have growth defects and/or instability of the fluorescent protein markers 10, 11 . We therefore engineered an improved RFP for whole-cell labeling.
We first evaluated cytotoxicity for mEGFP and 11 RFPs (Supplementary Results online). During constitutive high-level expression in Escherichia coli, mEGFP was well tolerated, but the RFPs showed moderate to severe cytotoxicity as judged by colony size ( Supplementary Fig. 1 online) . To assess cytotoxicity in HeLa cells, we expressed fluorescent proteins by transient transfection with a plasmid containing the strong CMV promoter and analyzed viable fluorescent cells by flow cytometry daily after transfection. For mEGFP, average cellular fluorescence remained nearly constant from 24 to 120 h (Fig. 1a) . In contrast, average fluorescence of all of the RFPs progressively declined (Fig. 1a) because of preferential loss of the most highly expressing cells (Supplementary Fig. 2 online) . Expression of RFPs caused many cells to detach from the growth surface (data not shown), further indicating cytotoxicity.
To generate a noncytotoxic RFP, we modified an existing protein that showed fast maturation and high photostability. Among the 11 RFPs tested, DsRed-Express, Katushka and mCherry matured the fastest (Supplementary Table 1 and Supplementary Fig. 3a online). We assessed photostability using a simple assay involving illumination through an epifluorescence microscope at a fixed light intensity ( Supplementary Fig. 3b and Supplementary Methods online) because this configuration mimics the typical experience for many researchers. DsRed-Express was by far the most photostable of the RFPs (Supplementary Table 1 ). We therefore chose DsRed-Express as the starting point.
The cytotoxicity of DsRed-Express may stem from aggregation 11 . We measured aggregation using an assay in which bacteria expressing a fluorescent protein were lysed and centrifuged 2 . With DsRedExpress, 450% of the fluorescence was in the pellet (Fig. 1b) . We used directed evolution of the DsRed-Express protein surface to reduce higher-order aggregation as measured by the bacterial extraction assay (Supplementary Results, Supplementary Figs. 4 and 5, and Supplementary Tables 2-5 online). One mutation boosted solubility but nullified a change that had increased bacterial expression, requiring re-optimization of bacterial expression (Supplementary Results). The final resulting protein, DsRed-Express2, retained the favorable fluorescence properties of DsRed-Express but was as soluble as mEGFP during bacterial extraction (Fig. 1b) .
DsRed-Express2 is not as bright as wild-type DsRed, so we mutagenized it to create DsRed-Max, which was B30% brighter than DsRed-Express2 and retained high solubility ( Fig. 1b and Supplementary Results). DsRed-Max had lower green emission than DsRed-Express2 ( Supplementary Fig. 6 online), but was slower to mature and more photolabile (Supplementary Table 1 and Supplementary Fig. 7 online). DsRed-Max should be useful when brightness and/or pure red emission are most important.
E. coli cells constitutively expressing DsRed-Express2 or DsRedMax produced large colonies similar to those obtained with mEGFP ( Fig. 1c) . Transiently transfected HeLa cells expressing DsRed-Express2 or DsRed-Max maintained nearly constant average fluorescence (Fig. 1d) , and the highly expressing cells remained viable ( Supplementary Fig. 2 ). Thus, with both bacterial and mammalian plasmid expression vectors, DsRed-Express2 and DsRed-Max are tolerated better than any of the other RFPs tested.
For mammalian cells, an alternative to plasmid-based expression is retroviral transduction, which yields long-term expression at moderately high levels 12 . We used a commercial lentiviral system to compare DsRed-Express2 with five other RFPs and mEGFP. We transduced HeLa cells using the same lentiviral titer for each fluorescent protein and then analyzed viable fluorescent cells by flow cytometry after 3 and 10 d. At day 3, the fluorescence signal over background was stronger for DsRed-Express2 than for any other RFP (Fig. 2a) . At day 10, the average fluorescence intensity was nearly unchanged for mEGFP and DsRed-Express2, but had dropped substantially for the other fluorescent proteins, presumably owing to a loss of the most highly expressing cells. This interpretation was supported by counting the percentage of viable cells that were fluorescent. Between days 3 and 10, this percentage was nearly unchanged for mEGFP and DsRed-Express2 but dropped substantially for the other fluorescent proteins (Fig. 2b) . Even at day 3, we observed relatively few fluorescent cells with DsRed-Monomer, TagRFP and TurboRFP, possibly reflecting cytotoxicity at early stages of expression. In a separate experiment, lentivirally transduced HeLa cells containing DsRedExpress showed a lag in growth compared to cells containing DsRed-Express2 or mEGFP (Fig. 2c) .
Next we tested DsRed-Express2 in a context where fluorescent protein cytotoxicity had previously hindered an experimental analysis. A suitable system was suggested by a report 11 in which mouse bone marrow cells had been retrovirally transduced to express either EGFP or DsRed-Express, and then grown in vitro under culture conditions that favored the preservation and growth of hematopoietic stem and progenitor cells. The cells containing EGFP grew robustly whereas those containing DsRed-Express did not. To test DsRed-Express2 in this system we transduced mouse At day 0, the cells containing DsRed-Express2 were more abundant and were on average twice as bright as those containing DsRed-Express (Fig. 3a) . The cells containing DsRed-Express2 proliferated to the same degree as those containing EGFP, but the cells containing DsRed-Express proliferated much less (Fig. 3b) . These data are similar to the results with HeLa cells. We conclude that DsRedExpress2 is minimally cytotoxic in a variety of cell types. DsRed-Express2 has additional advantages. It is excited efficiently by both blue and green lasers that are routinely used in flow cytometers. In bacteria, DsRed-Express2 is expressed from the endogenous start codon much more strongly than DsRed-Express ( Supplementary Fig. 4 ). Another important property is phototoxicity, which has only rarely been measured for engineered fluorescent proteins. Our results indicate that DsRed-Express2 has low phototoxicity (Supplementary Results and Supplementary Fig. 8 online) . Thus, for whole-cell labeling, DsRed-Express2 is the RFP of choice.
DsRed-Express2 is likely to be well-tolerated in transgenic organisms. Although the previously available RFPs have been used successfully to generate fluorescent animals 4, 13, 14 , those findings probably reflect a threshold effect in which a cytotoxic fluorescent protein is tolerated up to a certain concentration. We suspect that the transgenes in earlier studies were expressed at relatively low levels and may sometimes have caused residual cytotoxicity. DsRed-Express2 should facilitate the production of healthy transgenic organisms with strong and stable red fluorescence. Similar improvements can be expected when fluorescent cells are transplanted into animal hosts 15 . For example, when retrovirally transduced mouse hematopoietic stem cells had been transplanted into mice, cells expressing EGFP were maintained, but those expressing DsRed-Express were progressively lost 11 . This result suggests that cytotoxicity in cultured cells can predict the behavior of a fluorescent protein in vivo.
Because DsRed-Express2 and DsRed-Max are tetramers, they are best suited to labeling whole cells rather than making fusion proteins. Future modifications of the chromophore environment of these fluorescent proteins should enable us to create additional noncytotoxic whole-cell labels.
Sequences were deposited in GenBank for DsRed-Express2 (FJ226077) and DsRed-Max (FJ226078). The crystal structure of DsRed-Max was solved and deposited in the Protein Data Bank (2V4E).
Note: Supplementary information is available on the Nature Methods website. 
